Join our daily newsletter At The Bell to receive exclusive market insights
Cardiex (ASX:CDX) shares have today remained flat on a happier Tuesday ahead of this month’s RBA decision as its CONNEQT cardiovascular health software integrates with the Apple Health application.
Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.
Clearly, that news hasn’t been enough to bring a saving dose of liquidity to the stock.
Still, Cardiex customers with a CONNEQT Pulse Monitor – which Cardiex bills as “the world’s most advanced personal arterial health monitor” on its website – can now link that monitor to the Apple Health app.
(One must also have the CONNEQT App to do this, which apparently allows users to boost their “arterial intelligence.” Whatever that means.)
“Once connected, select biomarker results are automatically updated and accessible within the Health Records section of the [Apple] app,” Cardiex wrote on Tuesday.
“This allows users to view their data in one convenient and secure location on their iPhone in addition to the CONNEQT App.”
Why that duplication would be beneficial remains to be seen but the popularity of Apple products could be a boon here for the company. Still, that duplication concern may also be why investors aren’t rushing to snag CDX shares.
There’s also the fact it only applies to US customers using the latest version of iOS.
More market news
Never-ending: And just like that, Trump’s tariffs are back causing more market chaos
Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst
“By integrating with Apple Health Records, we are putting important health information at our patients’ fingertips, helping them make informed decisions and manage their health more effectively,” CDX CEO Craig Cooper said.
CDX last traded at 7.5cps.
Join the discussion: See what HotCopper users are saying about Cardiex and be part of the conversations that move the markets.
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
